Showing results (61-70 of 8,391) with videos related to
Sort By:
Pageof 840
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 11, 2012
Accurate measurement of oxygen consumption in children undergoing cardiac catheterizationJia LiJournal of Biological Dynamics|October 1, 2016
New revised simple models for interactive wild and sterile mosquito populations and their dynamicsJia LiJournal of Biological Dynamics|August 11, 2012
Differential equations models for interacting wild and transgenic mosquito populationsJia LiMedical Devices (Auckland, N.Z.)|April 3, 2026
A Multidimensional Index Framework for Evaluating the Regulatory Applicability of ISO 10328 Using a Prosthetic Knee Case StudyJia LiThe Journal of Investigative Dermatology|June 11, 2017
p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein SynthesisNicholas Theodosakis, Goran Micevic, Casey G Langdon, et al.Molecular Cancer Research : MCR|May 16, 2014
Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cellsVikram B Wali, Jonathan W Haskins, Maureen Gilmore-Hebert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patientsMichael P DiGiovanna, David F Stern, Susan M Edgerton, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 2004
ErbB2 is required for ductal morphogenesis of the mammary glandAmy J Jackson-Fisher, Gary Bellinger, Rajani Ramabhadran, et al.Cancer Research|June 25, 2013
EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasisJerrica L Breindel, Jonathan W Haskins, Elizabeth P Cowell, et al.Pigment Cell & Melanoma Research|October 4, 2018
Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancerNicholas Theodosakis, Casey G Langdon, Goran Micevic, et al.Pageof 840